The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages

  Lawn, Richard M ^a   Wade, David P ^a   Garvin, Michael R ^a   Wang, Xingbo ^a   Schwartz, Karen ^a   Gordon Porter, J ^b   Seilhamer, Jeffrey J ^b   Vaughan, Ashley M ^c   Oram, John F ^c  

^a CV THERAPEUTICS INC   (United States)

^b Experimental Station   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN; CYCLIC AMP; LIPID;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANGIER DISEASE;

EID: 0032725185     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8119     Document Type: Article

References (38)

1. Glomset, J.A. 1968. The plasma lecithin: cholesterol acyltransferase reaction. J. Lipid Res. 9:155-167.
2. Fielding, C.J., and Fielding, P.E. 1997. Intracellular cholesterol transport. J. Lipid Res. 38:1503-1521.
3. Oram, J.F., and Yokoyama, S. 1996. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37:2743-2491.
4. Mendez, A.J. 1997. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38:1807-1821.
5. Remaley, A.T., et al. 1997. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Arterioscler. Thromb. Vasc. Biol. 17:1813-1821.
6. Mendez, A.J., and Uint, L. 1996. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. J. Lipid Res. 37:2510-2524.
7. Fredrickson, D.S. 1964. The inheritance of high density lipoprotein deficiency (Tangier disease). J. Clin. Invest. 43:228-236.
8. Assmann, G., von Eckardstein, A., and Brewer, H.B. 1995. Familial HDL deficiency: Tangier disease. In The metabolic basis of inherited disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, NY. 2053-2072.
9. Serfaty-Lacrosniere, C., et al. 1994. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 107:85-98.
10. Francis, G.A., Knopp, R.H., and Oram J.F. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96:78-87.
11. Rogler, G., Trümbach, B., Klima, B., Lackner, K.J., and Schmitz, G. 1995. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 15:683-690.
12. Walter, M., Gerdes, U., Seedorf, U., and Assmann, G. 1994. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205:850-856.
13. Horowitz, B.S., et al. 1993. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J. Clin. Invest. 91:1743-1752.
14. Rothblat, G.H., et al. 1999. Cell cholesterol efflux. Integration of old and new observations provides new insights. J. Lipid Res., 40:781-796.
15. Dean, M., and Allikmets, R. 1995. Evolution of ATP-binding cassette transporter genes. Curr. Opin. Genet. Dev. 5:779-785.
16. Higgins, C.F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:67-113.
17. Oram, J.F., Mendez, A.J., Lymp, J., Kavanagh, T.J., and Halbert, C.L. 1999. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells. J. Lipid Res. In press.
18. DeRisi, J.L., Iyer, V.R., and Brown, P.O. 1997. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 24:680-686.
19. Smith, J.D., et al. 1996. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271:30647-30655.
20. Walker, J., et al. 1993. The adenosine 5′, 5‴, P1,P4-tetraphosphate receptor is at the cell surface of heart cells. Biochemistry. 50:14009-14014.
21. Rust, S., et al. 1998. Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat. Genet. 20:96-98.
22. Luciani, M.F., Denizot, F., Savary, S., Mattei, M.G., and Chimini, G. 1994. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics. 21:150-159.
23. Smit, J.J.M., et al. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:451-462.
24. Strautnieks, S.S., et al. 1998. A gene encoding a liver-specific ABC transporter is mutated in familial intrahepatic cholestasis. Nat. Genet. 20:233-238.
25. Becq, F., et al. 1997. ABCl, an ATP binding cassette transporter required during apoptosis, generates a regulated anion flux after expression in Xenopus oocytes. J. Biol. Chem. 272:2695-2699.
26. Hamon, Y., et al. 1997. Interleukin 1-beta secretion is impaired by inhibitors of the ATP binding cassette transporter, ABCl. Blood. 90:2911-2915.
27. Langmann, T., et al. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABCl): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257:29-33.
28. Hokland, B.M., Slotte, J.P., Bierman, E.L., and Oram, J. F. 1993. Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells. J. Biol. Chem. 268:25343-25349.
29. Oram, J.F., Mendez, A.J., Slotte, J.P., and Johnson, T.F. 1991. High density lipoprotein apolipoprotein mediated removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11:403-414.
30. Stein, O., and Stein, Y. 1999. Atheroprotective mechanisms of HDL. Atherosclerosis. 144:285-301.
31. Fielding, P.E., and Fielding, C.J. 1995, Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry. 34:14288-14292.
32. Brown, M.S., and Goldstein, J.L. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:34-47.
33. Brown, M.S., and Goldstein, J.L. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:223-261.
34. Hyde, S.C., Emsley, P., Hartshorn, M.J., Mimmack, M.M., and Gileadi, U. 1990. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature. 346:362-365.
35. Allikmets, R., Gerrard, B., Hutchinson, A., and Dean, M. 1996. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the Expressed Sequence Tags database. Hum. Mol. Genet. 5:1649-1655.
36. Brooks-Wilson, A., et al. 1999. Mutations in ABCl in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:336-345.
37. Bodzioch, M., et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:347-351.
38. Rust, S., et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:352-355.